Back to User profile » Dr Kang Li
Papers published by Dr Kang Li:
Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model
Xiong Y, Qiao W, Mei T, Li K, Jin R, Zhang Y
Journal of Hepatocellular Carcinoma 2024, 11:1375-1388
Published Date: 8 July 2024
Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments
Qiao W, Xiong Y, Li K, Jin R, Zhang Y
Journal of Hepatocellular Carcinoma 2024, 11:1113-1125
Published Date: 13 June 2024
During the Omicron Pandemic Wave, the Severe Systemic Inflammatory Status of COVID-19 Indicated a Higher Risk of In-Hospital Mortality and Mediated the Clinical Efficacy of Corticosteroids
Cao Y, Han Y, Wu J, Sun J, Dai Y, Qiao G, Li K, Li A, Zhang Y, Ma Y, Song Q
Infection and Drug Resistance 2023, 16:7377-7387
Published Date: 30 November 2023
A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies
Wang Q, Ma L, Li J, Yuan C, Sun J, Li K, Qin L, Zang C, Zhao Y, Zhao Y, Zhang Y
Cancer Management and Research 2019, 11:10641-10649
Published Date: 20 December 2019